期刊文献+

EPO对AD样大鼠海马组织氧化应激反应的影响

Effects of EPO on oxidative stress in Hippocampus of Rats with Alzheimer's disease
下载PDF
导出
摘要 目的观察EPO对Alzheimer样大鼠总抗氧化能力、过氧化氢酶活性、一氧化氮含量及一氧化氮合酶活性的影响。方法 SD大鼠随机分为生理盐水组、AD模型组、EPO治疗组。采用淀粉样蛋白β(Aβ)直接海马注射建造阿尔茨海默病(AD)模,生理盐水组海马注射等量生理盐水,EPO治疗组从造模后第1起腹腔注射浓度为5000IU/kg的重组人促红细胞生成素(rHu-EPO)治疗10天(2天1次)。并应用分光光度法测定大鼠海马组织T—AOC、CAT活性、NO含量及NOS活性。结果与生理盐水组和EPO治疗组相比,AD模型组的T—AOC和CAT活性明显降低(P<0.05),NO含量及NOS活性明显升高(P<0.05)。结论 EPO能够提高AD样大鼠海马组织的抗氧化能力,明显地减轻氧化应激反应对AD样大鼠海马组织的损害。 Objective To explore the effect of EPO on T--AOC CATNO and NOS in Hippocampus of Alzheimer' s disease Rats. Methods Spraque-Dawley rats were randomly separated into 3 groups:saline group, AD model group and EPO-treatment group. With amlyoid beta-protein(Aβ)injection into rat hippocampus made Alzheimer' s disease model. Hippocampus of saline group injected normal saline. EPO-treatment group was treated 10 days( 1 times 2 days) by intraperitoneal injection of Concentration for 5 000 iu/kg of rHu-EPO from the first day after the modeling. T--AOC^CAT^NO and NOS in rats' hip- pocampus were assayed by spectrophotometry. Results Compared to the saline group and the EPO - treatment group, the ability of T--AOC and the activity of CAT in rats' hippocampus of AD model group were decreased ( P 〈0. 05 ) , but the contents of NO and the activity of NOS were increased in AD model group (P 〈 0.05). Conclusion EPO may raise the anti-oxidant ability of hippoeampus tissue of Alzhei- mer' s disease Rats, significantly decrease injury of oxidative stress in hippoeampus of rats with Alzbei- mer' s disease.
出处 《河南职工医学院学报》 2013年第2期124-127,共4页 Journal of Henan Medical College For Staff and Workers
关键词 促红细胞生成素 Β淀粉样蛋白 氧化应激 海马 EPO oxidative hippocampus
  • 相关文献

参考文献25

  • 1Selkoe D J. Alzheimer’s disease : Genes, proteins, and therapy[J]. PHYSIOLOGICAL REVIEWS,2001 ,81(2).
  • 2Barkats M,Abrioux P, Mallet J. Overexpression of glutathioneperoxidase increases the resistance of neuronal cells to Abeta - me-diated neurotoxicity. [ J ]. Journal of neurochemistry, 2000, 75(4):1 438 -1 446.
  • 3Boldogh I,Kmzel M L. Colostrinin ( TM ) : An oxidative stressmodulator for prevention and treatment of age - related disorders[J]. Journal of alzheimers disease,2008 ,13(3).
  • 4Moon J H , Kim S Y, Lee H G, et al. Activation of nicotinic ace-tylcholine receptor prevents the production of reactive oxygen spe-cies in fibrillar beta amyloid peptide ( 1 - 42) - stimulated micro-glia [ J ]. Experimental and molecular medigine, 2008 ,40 ( 1 ) :11-18.
  • 5Sultana R, Mohmmad - Abdul H, Butterfield D A. Protectiveeffect of the xanthate,D609,on Alzheimer’s amyloid beta - pep-tide (1 - 42) - induced oxidative stress in primary neuronal cells[J]. Free radical research ,2004,38 (5 ) :449 -458.
  • 6Fisher J W. Erythropoietin; Physiology and pharmacology update[J]. Experimental biology and medicine,2003 ,228 (1 ).
  • 7Gonzalez F F,Mu D, Wendland M, et al. Erythropoietin en-hances long-term neuroprotection and neurogenesis in neonatalstroke[ J ] . Developmental neuroscience, 2007 , 29 ( 4 - 5 ) : 321-330.
  • 8Gras so G,Sfacteria A,Meli F,et al. Neuroprotection by erythro-poietin administration after experimental traumatic brain injury[J]. Brain research,2007 :99 - 105.
  • 9Lykissas M G,Vekris M D , Sakellariou E. The role of erythropoi-etin in central and peripheral nerve injury [ J ]. Clinical neurologyand neurosurgery 12007 ,109 (8) :639 - 644.
  • 10Wu Y, Sun S,Yang W. Protective effect of erythropoietin against1 -methyl-4-phenylpyridinium - induced neurodegenaration in PC 12cells. [ J] . Neuroscience bulletin ,2007 ,23 (3 ) : 156 - 164.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部